NM_000439.5:c.1993C>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000439.5(PCSK1):​c.1993C>G​(p.Gln665Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.265 in 1,613,634 control chromosomes in the GnomAD database, including 57,709 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.24 ( 4653 hom., cov: 32)
Exomes 𝑓: 0.27 ( 53056 hom. )

Consequence

PCSK1
NM_000439.5 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.110

Publications

85 publications found
Variant links:
Genes affected
PCSK1 (HGNC:8743): (proprotein convertase subtilisin/kexin type 1) This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an initial autocatalytic processing event in the ER to generate a heterodimer which exits the ER and sorts to subcellular compartments where a second autocatalytic even takes place and the catalytic activity is acquired. The protease is packaged into and activated in dense core secretory granules and expressed in the neuroendocrine system and brain. This gene encodes one of the seven basic amino acid-specific members which cleave their substrates at single or paired basic residues. It functions in the proteolytic activation of polypeptide hormones and neuropeptides precursors. Mutations in this gene have been associated with susceptibility to obesity and proprotein convertase 1/3 deficiency. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene [provided by RefSeq, Jan 2014]
CAST (HGNC:1515): (calpastatin) The protein encoded by this gene is an endogenous calpain (calcium-dependent cysteine protease) inhibitor. It consists of an N-terminal domain L and four repetitive calpain-inhibition domains (domains 1-4), and it is involved in the proteolysis of amyloid precursor protein. The calpain/calpastatin system is involved in numerous membrane fusion events, such as neural vesicle exocytosis and platelet and red-cell aggregation. The encoded protein is also thought to affect the expression levels of genes encoding structural or regulatory proteins. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jun 2010]
CAST Gene-Disease associations (from GenCC):
  • peeling skin-leukonuchia-acral punctate keratoses-cheilitis-knuckle pads syndrome
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003394097).
BP6
Variant 5-96393270-G-C is Benign according to our data. Variant chr5-96393270-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 354640.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.297 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PCSK1NM_000439.5 linkc.1993C>G p.Gln665Glu missense_variant Exon 14 of 14 ENST00000311106.8 NP_000430.3 P29120-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PCSK1ENST00000311106.8 linkc.1993C>G p.Gln665Glu missense_variant Exon 14 of 14 1 NM_000439.5 ENSP00000308024.2 P29120-1

Frequencies

GnomAD3 genomes
AF:
0.243
AC:
36901
AN:
151924
Hom.:
4658
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.191
Gnomad AMI
AF:
0.155
Gnomad AMR
AF:
0.205
Gnomad ASJ
AF:
0.279
Gnomad EAS
AF:
0.308
Gnomad SAS
AF:
0.310
Gnomad FIN
AF:
0.278
Gnomad MID
AF:
0.247
Gnomad NFE
AF:
0.267
Gnomad OTH
AF:
0.251
GnomAD2 exomes
AF:
0.266
AC:
66704
AN:
251072
AF XY:
0.271
show subpopulations
Gnomad AFR exome
AF:
0.188
Gnomad AMR exome
AF:
0.200
Gnomad ASJ exome
AF:
0.287
Gnomad EAS exome
AF:
0.308
Gnomad FIN exome
AF:
0.285
Gnomad NFE exome
AF:
0.274
Gnomad OTH exome
AF:
0.258
GnomAD4 exome
AF:
0.268
AC:
391365
AN:
1461592
Hom.:
53056
Cov.:
36
AF XY:
0.269
AC XY:
195692
AN XY:
727100
show subpopulations
African (AFR)
AF:
0.183
AC:
6126
AN:
33452
American (AMR)
AF:
0.199
AC:
8876
AN:
44690
Ashkenazi Jewish (ASJ)
AF:
0.292
AC:
7640
AN:
26120
East Asian (EAS)
AF:
0.263
AC:
10449
AN:
39698
South Asian (SAS)
AF:
0.305
AC:
26330
AN:
86248
European-Finnish (FIN)
AF:
0.285
AC:
15204
AN:
53416
Middle Eastern (MID)
AF:
0.236
AC:
1361
AN:
5768
European-Non Finnish (NFE)
AF:
0.269
AC:
299352
AN:
1111820
Other (OTH)
AF:
0.265
AC:
16027
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
16486
32971
49457
65942
82428
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10052
20104
30156
40208
50260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.243
AC:
36892
AN:
152042
Hom.:
4653
Cov.:
32
AF XY:
0.242
AC XY:
17999
AN XY:
74304
show subpopulations
African (AFR)
AF:
0.191
AC:
7905
AN:
41468
American (AMR)
AF:
0.205
AC:
3134
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.279
AC:
968
AN:
3468
East Asian (EAS)
AF:
0.307
AC:
1584
AN:
5158
South Asian (SAS)
AF:
0.310
AC:
1490
AN:
4806
European-Finnish (FIN)
AF:
0.278
AC:
2932
AN:
10564
Middle Eastern (MID)
AF:
0.241
AC:
71
AN:
294
European-Non Finnish (NFE)
AF:
0.267
AC:
18140
AN:
67980
Other (OTH)
AF:
0.250
AC:
527
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1409
2818
4226
5635
7044
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
388
776
1164
1552
1940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.265
Hom.:
4212
Bravo
AF:
0.238
TwinsUK
AF:
0.272
AC:
1009
ALSPAC
AF:
0.288
AC:
1109
ESP6500AA
AF:
0.193
AC:
849
ESP6500EA
AF:
0.279
AC:
2397
ExAC
AF:
0.269
AC:
32618
Asia WGS
AF:
0.280
AC:
973
AN:
3478
EpiCase
AF:
0.269
EpiControl
AF:
0.276

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Dec 19, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
May 26, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 28271036, 23383060, 25625282, 24932808) -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Monogenic Non-Syndromic Obesity Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Obesity due to prohormone convertase I deficiency Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.051
BayesDel_addAF
Benign
-0.73
T
BayesDel_noAF
Benign
-0.68
CADD
Benign
0.062
DANN
Benign
0.60
DEOGEN2
Benign
0.14
T;.
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.015
N
LIST_S2
Benign
0.016
T;T
MetaRNN
Benign
0.0034
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.69
N;.
PhyloP100
0.11
PrimateAI
Benign
0.30
T
PROVEAN
Benign
0.13
N;N
REVEL
Benign
0.081
Sift
Benign
1.0
T;T
Sift4G
Benign
1.0
T;T
Polyphen
0.0
B;.
Vest4
0.011
MPC
0.28
ClinPred
0.0016
T
GERP RS
-0.27
Varity_R
0.031
gMVP
0.11
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6234; hg19: chr5-95728974; COSMIC: COSV60735461; API